✦ LIBER ✦

Multiple family group therapy with adolescents in a state hospital

✍ Scribed by Ruth McClendon

Publisher: Springer
Year: 1976
Tongue: English
Weight: 690 KB
Volume: 4
Category: Article
ISSN: 0091-1674
DOI: 10.1007/bf02142634

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A credo for responsible group therapy wi

A credo for responsible group therapy with hospitalized adolescents

✍ Harriet S. Fisher 📂 Article 📅 1976 🏛 Springer 🌐 English ⚖ 349 KB

Evolution of group therapy policies with

Evolution of group therapy policies with hospitalized drug addicts in the narcotic unit at Central Islip State Hospital

✍ Stanley Robert Brett; André Villeneuve 📂 Article 📅 1963 🏛 Springer US 🌐 English ⚖ 275 KB

Effectiveness of self-esteem and social

Effectiveness of self-esteem and social skills group therapy in adolescent eating disorder patients attending a day hospital treatment programme

✍ L. Lázaro; E. Font; E. Moreno; R. Calvo; M. Vila; S. Andrés-Perpiñá; G. Canalda; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

A brief questionnaire to assess readines

A brief questionnaire to assess readiness to change in adolescents with eating disorders: its applications to group therapy

✍ Joanne Gusella; Gordon Butler; Laura Nichols; Debbie Bird 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

The clinical impact and molecular biolog

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy

✍ Kevin D. Boyd; Fiona M. Ross; William J. Tapper; Laura Chiecchio; GianPaolo Dagr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract Hemizygous deletion of 17p (del(17p)) has been identified as a variable associated with poor prognosis in myeloma, although its impact in the context of thalidomide therapy is not well described. The clinical outcome of 85 myeloma patients with del(17p) treated in a clinical trial incor

Circulating angiopoietin-1 to angiopoiet

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

✍ Evangelos Terpos; Konstantinos Anargyrou; Eirini Katodritou; Efstathios Kastriti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

## Abstract The circulating levels of several angiogenic cytokines [angiopoietin‐1 (Ang‐1), angiopoietin‐2 (Ang‐2), vascular endothelial growth factor (VEGF), angiogenin and basic fibroblast growth factor (bFGF)] were evaluated in 174 consecutive patients with newly diagnosed, symptomatic, multiple